|COMMENT||$65.610||CAUTIOUS||NORTH AMERICAN - LARGE||Yes|
Will be splitting the company into 2 parts, pharma side and medical devices. Purchased a generic company out of India last year and India will be providing health care to the general population but will only pay for generic drugs . Currently within a couple of dollars of her target price so she might shave some of her holdings.
CEO & Managing Director, GlobeInvest Capital Management